Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Target Price
The average target price of NMTC is 2.1 and suggests 178% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell